WHO ICTRP trial
Exploratory study of DPP-4 inhibitor on glycemic control and organ protection in…
JPRN-UMIN000012171 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000012171 |
|---|---|
| Public title | Exploratory study of DPP-4 inhibitor on glycemic control and organ protection in type2 diabetic patients |
| Scientific title | Exploratory study of DPP-4 inhibitor on glycemic control and organ protection in type2 diabetic patients - Exploratory study of DPP-4 inhibitor on glycemic control and organ protection in type2 diabetic patients |
| Primary sponsor | Tokyo Jikei University School of Medicine Kashiwa Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase IV |
| Countries | Japan |
| Conditions | Type-2 diabetic patients (Type-2 diabetic patients with microalbuminuria or nephropathy) |
| Interventions | DPP-4 inhibitor (linagliptin) |
| Registration date | Oct 30, 2013 |
| Target size | 60 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: